cocaine has been researched along with Basal Ganglia Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friberg, L; Løkkegaard, A; Werdelin, LM | 1 |
| Amano, T; Fukuuchi, Y; Hashimoto, J; Itoh, Y; Kubo, A; Muramatsu, K; Sasaki, T | 1 |
| Dogra, VS; Lewis, D; Menon, PA; Poblete, J; Shyken, JM; Smeltzer, JS | 1 |
| Satel, SL; Swann, AC | 1 |
| D'Souza, DC; Krystal, JH; Madonick, S; Petrakis, IL | 1 |
| Eising, EG; Müller, T; Peters, S; Przuntek, H | 1 |
| Arilla, E; Rodríguez-Sánchez, MN | 1 |
| Dorn, JM; Dubin, WR; Weiss, KJ | 1 |
3 review(s) available for cocaine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Cannabis; Central Nervous System Stimulants; Cocaine; Cognition Disorders; Dopamine; Health Care Costs; Humans; Nicotine; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1999 |
Vascular Parkinsonism: a case report and review of the literature.
Topics: Basal Ganglia Diseases; Cerebral Arteries; Cocaine; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease, Secondary; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2001 |
Pharmacotherapy of psychiatric emergencies.
Topics: Amphetamines; Antipsychotic Agents; Anxiety Disorders; Basal Ganglia Diseases; Cocaine; Emergencies; Humans; Injections, Intramuscular; Phencyclidine; Psychotic Disorders; Substance-Related Disorders | 1986 |
5 other study(ies) available for cocaine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Basal Ganglia Diseases; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Dystonia; Essential Tremor; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Parkinsonian Disorders; Patient Care Management; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2002 |
[SPECT imaging using [123I]beta-CIT and [123I]IBF in extrapyramidal diseases].
Topics: Aged; Basal Ganglia Diseases; Benzofurans; Cocaine; Dopamine Plasma Membrane Transport Proteins; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pyrrolidines; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2003 |
Neurosonographic abnormalities associated with maternal history of cocaine use in neonates of appropriate size for their gestational age.
Topics: Alcohol Drinking; Basal Ganglia Diseases; Birth Weight; Body Constitution; Body Height; Brain Diseases; Caudate Nucleus; Cerebral Ventricles; Cocaine; Dilatation, Pathologic; Echoencephalography; Female; Gestational Age; Head; Humans; Infant, Newborn; Infant, Premature; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Substance-Related Disorders; Thalamic Diseases | 1994 |
Extrapyramidal symptoms and cocaine abuse.
Topics: Adult; Basal Ganglia Diseases; Cocaine; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Changes in striatal somatostatin receptors in pups after cocaine administration to pregnant and nursing dams.
Topics: Animals; Animals, Newborn; Basal Ganglia Diseases; Cocaine; Corpus Striatum; Female; Lactation; Maternal-Fetal Exchange; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Neurotransmitter; Receptors, Somatostatin; Up-Regulation | 1991 |